Andrew Paul Beelen

发表论文 164 篇 · 总被引 1186 次 · h-index 15

代表论文

Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer. (2024 · Carolina Digital Repository (University of North Carolina at Chapel Hill) · 被引 12)
Trilaciclib prior to FOLFOXIRI/bevacizumab for patients with untreated metastatic colorectal cancer: phase 3 PRESERVE 1 trial (2024 · JNCI Cancer Spectrum · 被引 8)
Trilaciclib combined with sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC): Updated phase 2 safety and efficacy results. (2024 · Journal of Clinical Oncology · 被引 3)
Supplementary Table S3 from [18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant (2026)
Supplementary Table S4 from [18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant (2026)
Supplementary Figure S1 from [18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant (2026)